Drug intelligence / Profile preview

autologous dedifferentiated fat cells

Development stage
Unknown
Lead developer
Nihon University
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intramuscular
01

Overview

Autologous dedifferentiated fat cells (DFAT cells) are a unique population of multipotent progenitor cells derived from mature adipocytes through a process called ceiling culture. Unlike traditional adipose-derived stem cells (ASCs) which are isolated from the stromal vascular fraction, DFAT cells are produced by inducing mature, lipid-filled fat cells to undergo dedifferentiation, reverting them to a fibroblast-like multipotent state. These cells exhibit high purity and a potent capacity for angiogenesis and tissue regeneration. In the treatment of peripheral artery disease (PAD) and critical limb ischemia (CLI), DFAT cells are typically administered via intramuscular injection into the affected limb. Their therapeutic effect is primarily mediated through paracrine signaling, involving the secretion of high levels of angiogenic factors such as vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF), as well as their ability to differentiate into vascular endothelial cells and smooth muscle cells to facilitate revascularization.

Other names
dedifferentiated adipocytesDFAT cellsceiling culture-derived cells

Beyond the preview

Go deeper on autologous dedifferentiated fat cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on autologous dedifferentiated fat cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call